恒敬合创生物医药（浙江）有限公司

恒敬合创生物医药（浙江）有限公司

浙江省嘉兴市中国浙江省嘉兴市南湖区大桥镇永叙路368号

2021

200至249

不愿意公开

恒敬生物根植于公司核心团队20多年的全球研发积累，创建国际领先的生物制药企业，自创成熟、高效、大规模、成本极具竞争力的生物医药产品，产品涵盖胰岛素类药物、GLP-1类药物以及更多的蛋白类、多肽类产品，位于嘉兴的先进工厂一期设计产能3吨原液和过亿支制剂，二期原液产能超10吨。Virtu Pharmako is a leading biopharmaceutical company with R&D, regulatory submission and CGMP manufacture engaged in four major business areas: Insulin drug portfolio, GLP-1 drug portfolio, biosynthetic technique corporations and varieties of protein/polypeptide bioproducts.With more than 20 years of global R&D study and commercial experiences, the company established the unique, innovative biotechnology platform which efficiently developed dozens of cost-competitive, environment friendly and commercial-scale biomedical products.Our state-of-art, world leading biopharmaceutical manufacture facility with building area 1 Million ft2 is built up in Jiaxing, Zhejiang, China, where located in near Metropolitan City, Shanghai. In Phase I, the production capacity includes 3 metric tonnes per year of API and over 120 million units per year of injectable. Production capacity of Phase II will surpasses 10 metric tonnes of API.

https://www.virtupharmako.com/

制造商

中国,北美洲,中/南美洲,西欧,东欧,大洋洲,中东,非洲,亚洲

Semaglutide（910463-68-2）;Semaglutide Intermediate（1169630-82-3）;Recombinant Insulin human（11061-68-0）;Insulin Aspart（116094-23-6）;Insulin Glargine（160337-95-1）;Insulin Degludec（844439-96-9）;Liraglutide（204656-20-2）

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

W4G51

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Finished Dosage;Biotech